tiprankstipranks
Trending News
More News >

Knight Therapeutics sees FY25 revenue C$390M-C$405M

Knight reconfirmed its financial guidance targets for 2025. Knight expects to generate between $390 million to $405 million in revenues and adjusted EBITDA to be approximately 13% of revenues.

Confident Investing Starts Here:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

1